IM
Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ·Healthcare·Biotechnology
$2.58
-0.40%
Mkt Cap $154.79M
Analyst Ratings
No recent rating data.
Price Target (10 analysts)
$9.75
Range $8.00 – $12.00
Implied Upside
+278.6%
Consensus $9.75 vs current $2.58